Element Biosciences, Inc.
Element Biosciences, Inc., headquartered in the United States, is a pioneering company in the genomics industry, specialising in innovative DNA sequencing technologies. Founded in 2017, Element has rapidly established itself as a leader in the field, focusing on providing accessible and cost-effective solutions for researchers and clinicians alike. The company’s flagship product, the Element AVITI System, offers a unique approach to next-generation sequencing, combining high throughput with exceptional accuracy. This technology is designed to meet the diverse needs of the genomics community, enabling advancements in areas such as personalised medicine and genetic research. With a commitment to transforming the landscape of DNA sequencing, Element Biosciences has garnered significant attention for its cutting-edge innovations and strategic partnerships, positioning itself as a formidable player in the rapidly evolving genomics market.
DitchCarbon Score
How does Element Biosciences, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Element Biosciences, Inc.'s score of 23 is lower than 78% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Element Biosciences, Inc.'s reported carbon emissions
Element Biosciences, Inc., headquartered in the US, currently does not have publicly available carbon emissions data for the most recent year, nor does it report specific reduction targets or initiatives. As of now, there are no emissions figures, such as Scope 1, 2, or 3 emissions, nor any commitments to science-based targets (SBTi) or other climate pledges. The absence of data suggests that Element Biosciences may still be in the early stages of developing its climate strategy or reporting framework. Without specific emissions data or reduction commitments, it is challenging to assess their environmental impact or sustainability efforts within the biotechnology sector. As the industry increasingly prioritises climate action, Element Biosciences may consider establishing measurable targets and transparent reporting to align with best practices and stakeholder expectations.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Element Biosciences, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
